Found 6 matching trials
Dendritic Cell Based Therapy of Malignant Melanoma PHASE1 The aim of the study is to show if vaccination with autologous dendritic ce...
Show More Location
Department of Oncology, Copenhagen University Hospital, Herlev
Learn More & Join Trial
Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients. PHASE2 This phase II, randomized, open-label trial aims to assess whether the vacc...
Show More Location
UO Immunoterapia e laboratorio TCS, IRST IRCCS
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma PHASE2 RATIONALE: Vaccines made from a person's white blood cells and a donor's tu...
Show More Location
Jonsson Comprehensive Cancer Center at UCLA
Learn More & Join Trial
T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma PHASE1 The purpose of this study is to learn if dendritic cell vaccine will increa...
Show More Location
Karolinska University Hospital
Learn More & Join Trial
Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes PHASE1 RATIONALE: Vaccines made from dendritic cells and tumor antigen peptides or...
Show More Location
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology - Warsaw
Learn More & Join Trial
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease. PHASE1 Assess the safety and tumor response of utilizing an autologous tumor lysat...
Show More Location
University of Alabama Birmingham Comprehensive Cancer Center
Learn More & Join Trial